These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36498925)

  • 1. Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer's Disease.
    Piancatelli D; Aureli A; Sebastiani P; Colanardi A; Del Beato T; Del Cane L; Sucapane P; Marini C; Di Loreto S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
    Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
    J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population.
    Sonali N; Tripathi M; Sagar R; Vivekanandhan S
    Int J Neurosci; 2013 Jun; 123(6):409-16. PubMed ID: 23270505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
    Laczó J; Cechova K; Parizkova M; Lerch O; Andel R; Matoska V; Kaplan V; Matuskova V; Nedelska Z; Vyhnalek M; Hort J
    J Alzheimers Dis; 2020; 78(4):1473-1492. PubMed ID: 33325388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
    Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Liou YJ
    Dement Geriatr Cogn Disord; 2006; 21(3):139-43. PubMed ID: 16391475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.
    Yu H; Zhang Z; Shi Y; Bai F; Xie C; Qian Y; Yuan Y; Deng L
    J Clin Psychiatry; 2008 Jul; 69(7):1104-11. PubMed ID: 18505307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
    Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
    J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression.
    Desai P; Nebes R; DeKosky ST; Kamboh MI
    Neurosci Lett; 2005 May; 379(3):229-34. PubMed ID: 15843069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
    Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
    J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Hsu LE; Lin CH
    Neuropsychobiology; 2004; 49(1):10-2. PubMed ID: 14730194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
    Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
    Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia.
    Nikolac Perkovic M; Borovecki F; Filipcic I; Vuic B; Milos T; Nedic Erjavec G; Konjevod M; Tudor L; Mimica N; Uzun S; Kozumplik O; Svob Strac D; Pivac N
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial DNAemia in Alzheimer's Disease and Mild Cognitive Impairment: Association with Cognitive Decline, Plasma BDNF Levels, and Inflammatory Response.
    Giacconi R; D'Aquila P; Balietti M; Giuli C; Malavolta M; Piacenza F; Costarelli L; Postacchini D; Passarino G; Bellizzi D; Provinciali M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.